Molecular Assemblies Appoints NuVasive Executive Sean Freeman to Board of Directors
June 15, 2017
SAN DIEGO, CA. — June 15, 2017— Molecular Assemblies Inc., a company developing a proprietary enzymatic DNA synthesis technology, today announced that it has expanded its board of directors with the appointment of Sean Freeman, NuVasive head of strategy and corporate development, to its board of directors. “Sean’s extensive business development experience in both strategic [...]
June 15, 2017
SAN FRANCISCO, Calif. – Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, and the BioBricks Foundation today announced a groundbreaking agreement to provide 10,000 genes to the synthetic biology community. Under the terms of the agreement, the BioBricks Foundation (BBF) will pay for synthesis of 10,000 genes from Twist Bioscience. [...]
June 14, 2017
Oslo, Norway/Herisau, Switzerland - CAMO Software and Metrohm announce a global partnership with integration of CAMO’s multivariate analysis software into the Lab Vis-NIR workflow with Metrohm’s Vis-NIR analyzers and spectroscopy software. Pharmaceutical and other regulated organizations with testing, quality control and laboratory environments will see important benefits that will help to maintain data integrity and transparency [...]
June 14, 2017
ACEA Biosciences Announces Successful Completion of Phase I Clinical Study of Novel Autoimmune Disease Drug San Diego, CA ACEA Biosciences today announced the completion of its Phase 1 clinical study of AC0058, a novel irreversible Bruton’s Tyrosine Kinase (BTK) inhibitor, which is in development for the treatment of B cell-related autoimmune diseases, including rheumatoid arthritis [...]
MACSprep™ PBMC Isolation Kit, human from Miltenyi Biotec
June 14, 2017
BERGISCH GLADBACH – The new MACSprep™ PBMC Isolation Kit, human from Miltenyi Biotec allows the preparation of highly pure peripheral blood mononuclear cells (PBMCs) from human whole blood without density gradient centrifugation in only 25 min. The kit is ideal for the processing of small blood samples. Miltenyi Biotec has developed the MACSprep PBMC Isolation Kit, [...]
MilliporeSigma Awarded its First CRISPR Patent by Australian Patent Office
June 14, 2017
Patent covers successful integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR Similar patents pending in other countries; anticipate favorable outcomes Billerica, Massachusetts — MilliporeSigma today announced that the Australian Patent Office has granted the company patent rights relating to the use of CRISPR in a genomic integration method for eukaryotic cells. The [...]
New Eppendorf Pipette Holder System
June 14, 2017
Carousels, stands and wall mount devices: The new Pipette Holder System is perfect for all users of handheld liquid handling instruments, who need a highly flexible system for their Eppendorf pipettes and Multipettes®. Carousels and stands provide a robust design with a small footprint. To save precious bench-top space, carousels carry both manual and electronic [...]
June 14, 2017
Diagenode’s new agreement with the CeMM Research Center of Molecular Medicine of the Austrian Academy of Sciences will enable ChIP-sequencing from low input and difficult samples Denville, NJ, USA Liège, Belgium – Diagenode, a leading global provider for complete solutions for sample preparation and epigenetics research, has licensed a new technology specific for ChIP-sequencing from [...]
908 Devices Introduces Next-Generation HPMS Device for the First Responder Community
June 14, 2017
MX908 brings enhanced detection and identification capabilities to modern-day response missions BOSTON -- 908 Devices, a pioneer of analytical devices for chemical and biomolecule analysis, today announced the release of MX908™, a second-generation handheld chemical detection and identification device powered by the Company’s patented and award-winning high-pressure mass spectrometry (HPMS™) technology. Designed for true trace-level detection [...]
June 14, 2017
Platform comprises Horizon’s viral, nuclease and transposon gene editing technologies for research and development Three new contract wins contributing a value of more than $2 million in 2017 with potential for long-term alliance development Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) ("Horizon" or “the Company”), the world leader in the application of gene editing [...]
